THE VALUE OF AUTOFLUORESCENCE ENDOSCOPY FOR THE DETECTION OF EARLY BARRETT*S CANCER

THE VALUE OF AUTOFLUORESCENCE ENDOSCOPY FOR THE DETECTION OF EARLY BARRETT*S CANCER - ABC study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32071

Enrollment

Registered

2008-04-24

Start date

2008-06-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients age >= 18 years scheduled for endoscopy because of recently diagnosed random HGD/EC lesions in Barrett*s Esophagus.

Exclusion criteria

Exclusion criteria: * Patients unable or unwilling to give informed consent * Coagulopathy uncorrected at the time of endoscopy or thrombocytopenia (

Design outcomes

Secondary

Measure	Time frame
1) The number of biopsy specimens needed to detect one HGD/EC lesion by the use of AFE guided biopsy specimens. 2) The number of biopsy specimens needed to detect one HGD/EC lesion by the use of video endoscopy FQRB. 3) Duration of the procedure for WLE, AF endoscopy and video endoscopy.	—

Primary

Measure	Time frame
The number of detected HGD/EC lesions in Barrett*s Esophagus in the FQRB by use of video endoscopy compared to the number of detected lesion by the autofluorescence guided targeted biopsy specimens.	—

Countries

Netherlands

Outcome results